{"id":59940,"date":"2024-09-02T19:05:10","date_gmt":"2024-09-02T17:05:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/"},"modified":"2024-09-02T19:05:10","modified_gmt":"2024-09-02T17:05:10","slug":"median-technologies-to-host-two-webcasts-on-september-5-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/","title":{"rendered":"Median Technologies to host two webcasts on September 5, 2024"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<strong><i>\u201c<\/i><\/strong><b><i>eyonis\u2122 LCS: New Horizons in Fighting Lung Cancer\u201d<\/i><\/b><\/p>\n<p>SOPHIA-ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/5\/Median_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/5\/Median_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/21\/Median_RGB.jpg\"><\/a><\/p>\n<p>\nMedian Technologies <i>(FR0011049824, ALMDT, PEA\/SME eligible, \u201cMedian\u201d or \u201cThe Company\u201d)<\/i> will host two live webcasts on September 5, 2024.<\/p>\n<p>\nFollowing the recent release of results of the eyonis\u2122 LCS REALITY study, Fredrik Brag, CEO and Founder of Median Technologies, will offer further insights into the significance of eyonis\u2122 LCS and discuss the next steps for Median&#8217;s novel Software as a Medical Device.<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nSeptember 5, 2024 &#8211; 4:00 pm CEST \/ 10:00 am EDT (English): <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fregister.gotowebinar.com%2Fregister%2F3357281131761462878%3Fsource%3DPR&amp;esheet=54116279&amp;newsitemid=20240902002418&amp;lan=en-US&amp;anchor=Sign-up+Link&amp;index=1&amp;md5=8257e96c1ce34c81afa351fc862af190\" rel=\"nofollow noopener\" shape=\"rect\"><i>Sign-up Link<\/i><\/a><\/li>\n<li>\nSeptember 5, 2024 &#8211; 6:00 pm CEST \/ 12:00 pm EDT (French): <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fregister.gotowebinar.com%2Fregister%2F5408449760191495257%3Fsource%3DPR&amp;esheet=54116279&amp;newsitemid=20240902002418&amp;lan=en-US&amp;anchor=Sign-up+Link&amp;index=2&amp;md5=351e1bc766a5b499d52b62f39278ba14\" rel=\"nofollow noopener\" shape=\"rect\"><i>Sign-up Link<\/i><\/a><\/li>\n<\/ul>\n<p>\nWebcast replays will be available on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmediantechnologies.com%2F&amp;esheet=54116279&amp;newsitemid=20240902002418&amp;lan=en-US&amp;anchor=Median%26%238217%3Bs+corporate+website&amp;index=3&amp;md5=6525ccfe824682130a46b75d075b992c\" rel=\"nofollow noopener\" shape=\"rect\">Median\u2019s corporate website<\/a> shortly after the live sessions.<\/p>\n<p>\n<strong>About Median Technologies: <\/strong>Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median&#8217;s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis\u2122, an AI\/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mediantechnologies.com&amp;esheet=54116279&amp;newsitemid=20240902002418&amp;lan=en-US&amp;anchor=www.mediantechnologies.com&amp;index=4&amp;md5=228a4cae238447b602607bd4a5e0fd17\" rel=\"nofollow noopener\" shape=\"rect\">www.mediantechnologies.com<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>MEDIAN TECHNOLOGIES<\/b><br \/>Emmanuelle Leygues<br \/>\n<br \/>Head of Corporate Marketing &amp; Financial Communications<br \/>\n<br \/>+33 6 10 93 58 88<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;&#111;:e&#x6d;&#x6d;&#x61;&#x6e;&#117;&#101;ll&#x65;&#x2e;&#x6c;&#x65;&#121;&#103;ue&#x73;&#x40;&#x6d;&#x65;&#100;&#105;&#97;nt&#x65;&#x63;&#x68;&#x6e;&#111;&#108;og&#x69;&#x65;&#x73;&#x2e;&#99;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#101;m&#x6d;a&#x6e;u&#x65;&#108;&#x6c;&#101;&#x2e;&#108;e&#x79;g&#x75;e&#x73;&#64;&#x6d;&#101;&#x64;&#105;&#x61;&#110;t&#x65;c&#x68;n&#x6f;&#108;&#x6f;&#103;&#x69;&#101;&#x73;&#46;c&#x6f;m<\/a><\/p>\n<p><b>U.S. media &amp; investors<\/b><br \/>Chris Maggos<br \/>\n<br \/><b>COHESION BUREAU<\/b><br \/>+41 79 367 6254<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;&#99;&#x68;&#114;&#x69;&#115;&#46;&#x6d;a&#x67;g&#x6f;&#115;&#x40;&#99;&#x6f;&#104;&#x65;&#115;i&#x6f;n&#x62;u&#x72;&#101;&#x61;&#117;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#x68;r&#x69;&#x73;&#46;&#x6d;a&#x67;&#x67;&#111;&#x73;&#64;&#x63;&#x6f;&#104;&#x65;s&#x69;&#x6f;&#110;&#x62;u&#x72;&#x65;&#97;&#x75;&#46;&#x63;&#x6f;&#109;<\/a><\/p>\n<p><b>Investors<\/b><br \/>Ghislaine Gasparetto<br \/>\n<br \/><b>SEITOSEI ACTIFIN<\/b><br \/>+33 6 21 10 49 24<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x67;&#x68;&#x69;&#x73;&#x6c;&#x61;&#x69;&#110;&#101;&#46;&#103;&#97;&#115;&#112;&#97;&#114;&#101;&#116;to&#64;seito&#x73;&#x65;&#x69;&#x2d;&#x61;&#x63;&#x74;&#x69;&#x66;&#x69;&#x6e;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">g&#104;&#105;&#x73;&#x6c;ai&#110;&#101;&#x2e;&#x67;as&#112;&#97;&#x72;&#x65;tt&#111;&#x40;&#x73;&#x65;i&#116;&#111;&#x73;&#x65;&#x69;-&#97;&#99;&#x74;&#x69;&#x66;i&#110;&#46;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p><b>Press<\/b><br \/>Caroline Carmagnol<br \/>\n<br \/><b>ALIZE RP<\/b><br \/>+33 6 64 18 99 59<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#x6f;:&#x6d;&#101;&#x64;&#x69;a&#x6e;&#64;&#x61;&#x6c;i&#x7a;&#101;&#x72;&#x70;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">med&#105;&#97;&#110;&#x40;&#x61;&#x6c;&#x69;&#x7a;&#x65;rp&#46;&#99;&#111;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u201ceyonis\u2122 LCS: New Horizons in Fighting Lung Cancer\u201d SOPHIA-ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA\/SME eligible, \u201cMedian\u201d or \u201cThe Company\u201d) will host two live webcasts on September 5, 2024. Following the recent release of results of the eyonis\u2122 LCS REALITY study, Fredrik Brag, CEO and Founder of Median Technologies, will offer further insights &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59940","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Median Technologies to host two webcasts on September 5, 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Median Technologies to host two webcasts on September 5, 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u201ceyonis\u2122 LCS: New Horizons in Fighting Lung Cancer\u201d SOPHIA-ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA\/SME eligible, \u201cMedian\u201d or \u201cThe Company\u201d) will host two live webcasts on September 5, 2024. Following the recent release of results of the eyonis\u2122 LCS REALITY study, Fredrik Brag, CEO and Founder of Median Technologies, will offer further insights ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-02T17:05:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Median Technologies to host two webcasts on September 5, 2024\",\"datePublished\":\"2024-09-02T17:05:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/\"},\"wordCount\":274,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240902002418\\\/en\\\/1343975\\\/22\\\/Median_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/\",\"name\":\"Median Technologies to host two webcasts on September 5, 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240902002418\\\/en\\\/1343975\\\/22\\\/Median_RGB.jpg\",\"datePublished\":\"2024-09-02T17:05:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240902002418\\\/en\\\/1343975\\\/22\\\/Median_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240902002418\\\/en\\\/1343975\\\/22\\\/Median_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-host-two-webcasts-on-september-5-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Median Technologies to host two webcasts on September 5, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Median Technologies to host two webcasts on September 5, 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/","og_locale":"en_US","og_type":"article","og_title":"Median Technologies to host two webcasts on September 5, 2024 - Pharma Trend","og_description":"\u201ceyonis\u2122 LCS: New Horizons in Fighting Lung Cancer\u201d SOPHIA-ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA\/SME eligible, \u201cMedian\u201d or \u201cThe Company\u201d) will host two live webcasts on September 5, 2024. Following the recent release of results of the eyonis\u2122 LCS REALITY study, Fredrik Brag, CEO and Founder of Median Technologies, will offer further insights ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/","og_site_name":"Pharma Trend","article_published_time":"2024-09-02T17:05:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Median Technologies to host two webcasts on September 5, 2024","datePublished":"2024-09-02T17:05:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/"},"wordCount":274,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/","url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/","name":"Median Technologies to host two webcasts on September 5, 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg","datePublished":"2024-09-02T17:05:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240902002418\/en\/1343975\/22\/Median_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-host-two-webcasts-on-september-5-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Median Technologies to host two webcasts on September 5, 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59940"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59940\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}